Genmab A/S (GMAB) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
GMAB Stock Price Trajectory (2011–2026)
As of February 28, 2026, Genmab A/S (GMAB) trades at $29.44, representing a +29.8% return over the past year. The stock has delivered a -3.5% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $103.19 on May 1, 2018. From this peak, GMAB has corrected -71.5%, currently trading 7% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and EXEL (+13.9% 1Y), GMAB has underperformed the peer group average. Compare GMAB vs RVMD →
Historical Price Data
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 29.39 | 29.48 | 29.15 | 29.44 | 29 | +0.68% |
| 2026-02-26 | 29.18 | 29.25 | 28.80 | 29.24 | 29 | -0.17% |
| 2026-02-25 | 29.16 | 29.60 | 28.99 | 29.29 | 29 | -0.37% |
| 2026-02-24 | 29.49 | 29.74 | 29.12 | 29.40 | 29 | +0.44% |
| 2026-02-23 | 28.42 | 29.28 | 28.42 | 29.27 | 29 | -0.07% |
| 2026-02-20 | 29.04 | 29.48 | 28.94 | 29.29 | 29 | +1.35% |
| 2026-02-19 | 28.28 | 29.00 | 28.06 | 28.90 | 2.10M | -0.89% |
| 2026-02-18 | 29.21 | 29.46 | 28.84 | 29.16 | 3.05M | -6.12% |
| 2026-02-17 | 29.66 | 31.26 | 29.66 | 31.06 | 262K | +3.43% |
| 2026-02-13 | 29.65 | 30.47 | 29.65 | 30.03 | 1.19M | +1.49% |
| 2026-02-12 | 30.05 | 30.17 | 29.47 | 29.59 | 1.37M | -1.56% |
| 2026-02-11 | 30.42 | 30.42 | 29.66 | 30.06 | 1.38M | -1.76% |
| 2026-02-10 | 30.87 | 31.00 | 30.59 | 30.60 | 894K | -0.87% |
| 2026-02-09 | 31.27 | 31.30 | 30.62 | 30.87 | 1.19M | -0.10% |
| 2026-02-06 | 30.94 | 31.31 | 30.75 | 30.90 | 1.76M | -0.23% |
| 2026-02-05 | 31.35 | 32.04 | 30.95 | 30.97 | 1.52M | -2.92% |
| 2026-02-04 | 32.45 | 32.56 | 31.41 | 31.90 | 1.53M | -3.42% |
| 2026-02-03 | 33.24 | 33.52 | 32.87 | 33.03 | 1.18M | -0.72% |
| 2026-02-02 | 32.66 | 33.37 | 32.66 | 33.27 | 880K | +1.96% |
| 2026-01-30 | 33.01 | 33.17 | 32.21 | 32.63 | 1.42M | -2.16% |
| 2026-01-29 | 33.23 | 33.38 | 32.79 | 33.35 | 1.19M | +1.28% |
| 2026-01-28 | 33.02 | 33.31 | 32.57 | 32.93 | 1.60M | -4.27% |
| 2026-01-27 | 33.76 | 34.68 | 33.73 | 34.40 | 2.01M | +2.78% |
| 2026-01-26 | 33.42 | 33.81 | 33.37 | 33.47 | 1.34M | -1.21% |
| 2026-01-24 | 33.35 | 33.92 | 33.21 | 33.88 | 1.73M | 0.00% |
| 2026-01-23 | 33.35 | 33.92 | 33.21 | 33.88 | 1.87M | +2.36% |
| 2026-01-22 | 32.91 | 33.49 | 32.79 | 33.10 | 1.17M | +0.46% |
| 2026-01-21 | 31.79 | 33.23 | 31.73 | 32.95 | 2.28M | +5.17% |
| 2026-01-20 | 31.38 | 31.70 | 31.04 | 31.33 | 2.76M | -2.85% |
| 2026-01-16 | 34.13 | 34.24 | 30.88 | 32.25 | 6.25M | -4.73% |
See GMAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GMAB Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare GMAB vs AGIO
See how GMAB stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has GMAB stock performed recently?
GMAB returned +29.8% over the past year, beating its 5-year annualized CAGR of -3.5%. The stock trades above its 200-day moving average, confirming the uptrend.
What is GMAB's all-time high price?
Genmab A/S reached $103.19 on 2018-05-01. The 52-week high is $35.43. Current 1-year return of +29.8% places the stock closer to historical peaks.
Where can I download GMAB historical price data?
This page provides GMAB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.